Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Twist Bioscience to Present at Upcoming Investor Conferences


Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences:

Both of these presentations will be webcast live and can be accessed by visiting the "Presentations" page of the investor relations section of the company's website here. Replays of the presentations will be archived for a period of 90 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube


These press releases may also interest you

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Octapharma USA and BioMatrix Specialty Pharmacy are supporting a new investigator-initiated research study led by Kelly McCants, M.D., Medical Director of the Norton Heart & Vascular Institute in Louisville, Ky., focused on treating patients with the...

at 09:04
New brand CarryOntm has launched sparkling CBD waters as well as a brand mission to normalize the pursuit of mental wellbeing.  With over 56% of Americans reporting negative effects on their mental wellbeing, CarryOntm believes that the pursuit of...

at 09:00
InspectIR Systems, LLC, a purpose-driven company with proprietary measurement methods, devices and tools, has begun clinical trials aimed at detecting the novel coronavirus (COVID-19). InspectIR partnered with University of North Texas Associate...

at 09:00
CAN Community Health announced that Tampa Family Pharmacy founders Haley Miller and Crystal Campbell have resigned effective immediately and sold their remaining interest to CAN Community Health to spend more time with their respective families....

at 09:00
PTC Therapeutics, Inc. today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5 at 10:00 a.m. ET....



News published on 13 november 2019 at 08:10 and distributed by: